Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Johnson & Johnson sees 'very viable path forward' for its COVID-19 vaccine despite safety, manufacturing setbacks
Abbott, J&J post rebounds in surgical sales, while COVID testing remains a cash cow for now
Bharat Biotech, government cash and partners in hand, aims for 700M COVID-19 shots per year
Global investment in telehealth, artificial intelligence hits a new high in Q1 2021
UPDATED Coronavirus tracker: Amazon's Alexa now able to connect users to vaccine sites
PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward
COVID-19 tracker: J&J resumes vaccine rollout in Europe; AstraZeneca's delayed COVAX supply resolved: UNICEF

Featured Story

Johnson & Johnson sees 'very viable path forward' for its COVID-19 vaccine despite safety, manufacturing setbacks

By Eric Sagonowsky

Johnson & Johnson's COVID-19 vaccine launch has hit pitfall after pitfall, but execs say they're confident the company can get back up to speed. The drugmaker plans to work with the FDA on a manufacturing site inspection and is 'cautiously optimistic' regulators will see the shot's benefits outweigh its risks.

Abbott, J&J post rebounds in surgical sales, while COVID testing remains a cash cow for now

By Conor Hale

Medical device companies continue to see their surgical sales recover to pre-COVID levels, and they're now delivering the first quarterly results that compare earnings to the earliest stages of the pandemic.

Bharat Biotech, government cash and partners in hand, aims for 700M COVID-19 shots per year

By Fraiser Kansteiner

India's Bharat Biotech is gunning to produce 700 million doses of its COVID-19 shot Covaxin a year, and it's won government cash and three new manufacturing partners help it reach that goal.

Global investment in telehealth, artificial intelligence hits a new high in Q1 2021

By Heather Landi

The first quarter of 2021 continued to see strong investor interest following 2020’s record highs. Telehealth investment hit an all-time high of $4.2 billion in just 139 deals in the first quarter of 2021. Healthcare AI also broke another funding record, according to CB Insights.

UPDATED Coronavirus tracker: Amazon's Alexa now able to connect users to vaccine sites

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward

By Ben Adams

Decentralized study company Medable has raised $78 million in its third funding round less than six months after grabbing $91 million.

COVID-19 tracker: J&J resumes vaccine rollout in Europe; AstraZeneca's delayed COVAX supply resolved: UNICEF

By Noah Higgins-Dunn,Fraiser Kansteiner,Eric Sagonowsky

Johnson & Johnson said it will resume its European vaccine rollout after the European Medicines Agency said the shot’s benefits still outweigh its risks, Reuters reports. Supply issues that hindered deliveries of AstraZeneca's vaccine to COVAX have been resolved, a UNICEF representative says. And more headlines.

COVID-19 Tracker